Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (May 6, 2013)
-
-
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 8, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 13, 2013)
-
Business Wire (Jan 22, 2013)
-
-
Business Wire (Jan 7, 2013)
-
Business Wire (Jan 7, 2013)
-
Strengthening Moats Mean Improving Returns For CRO InvestorsMorningstar • Mon, Dec 31, 2012 -
5 Stocks With Unusual VolumeMike King • Thu, Dec 13, 2012 -
Charles River Laboratories' CEO Discusses 2013 Guidance (Transcript)Wed, Dec 12, 2012
-
Business Wire (Dec 12, 2012)
-
3 Repurchase Plans For Fiscal UncertaintyPrescient Investment Analysis • Mon, Dec 10, 2012
To learn more about Seeking Alpha Pro, click here.
-
Buy One, Get One Free At Charles River LaboratoriesMorningstar • Sun, May 13, 2012
-
Charles River Placates Investors With More CutbacksThe Burrill Report • Thu, Dec 16, 2010 -
Charles River Falls Short as Higher Costs Take Their TollZacks Investment Research • Mon, Apr 26, 2010 -
-
Charles River Labs Looking for Second China FacilityChinaBio Today • Thu, May 7, 2009
-
Charles River Blames Slowdown on Biopharmas' Need to Conserve CashChinaBio Today • Sun, Nov 9, 2008
-
-
Charles River and Shanghai BioExplorer Open CRO FacilityChinaBio Today • Thu, Oct 16, 2008
-
Charles River Labs Attributes Success to "Virtualization" of PharmaChinaBio Today • Wed, Feb 13, 2008
-
-
Can Charles River Laboratories Make the Most of the Rat Race?James Hale • Wed, Feb 7, 2007
-
Charles River Laboratories: Driving The Rat RaceJames Hale • Wed, Nov 1, 2006
-
-
-
-
-
Strengthening Moats Mean Improving Returns For CRO InvestorsMorningstar • Mon, Dec 31, 2012
-
5 Stocks With Unusual VolumeMike King • Thu, Dec 13, 2012
-
3 Repurchase Plans For Fiscal UncertaintyPrescient Investment Analysis • Mon, Dec 10, 2012
-
-
-
-
-
-
-
-
16 Rallying Healthcare Stocks Being Sold By Hedge FundsKapitall • Tue, Feb 21, 2012
-
-
-
Contract Research Organizations Still On Sale As Industry ReboundsMorningstar • Thu, Jan 12, 2012
-
Hedge Funds Are Selling These 6 Biotech StocksKapitall • Wed, Jan 11, 2012
-
Top 10 Biotech Stocks Loved By Hedge FundsInsider Monkey • Thu, Dec 29, 2011
-
Charles River Laboratories' CEO Discusses 2013 Guidance (Transcript)Wed, Dec 12, 2012
-
Charles River Laboratories 2008 Guidance Call TranscriptThu, Dec 13, 2007
-
Charles River Laboratories Q3 2007 Earnings Call TranscriptTue, Nov 6, 2007
-
Business Wire (May 6, 2013)
-
Business Wire (May 1, 2013)
-
Business Wire (Apr 8, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 13, 2013)
-
Business Wire (Jan 22, 2013)
-
at CNBC.com (Jan 9, 2013)
-
Business Wire (Jan 7, 2013)
-
Business Wire (Jan 7, 2013)
-
at MarketWatch.com (Dec 12, 2012)
-
Business Wire (Dec 12, 2012)
-
Business Wire (Nov 29, 2012)
-
Business Wire (Oct 30, 2012)
-
Business Wire (Oct 30, 2012)
-
Business Wire (Oct 17, 2012)
-
Business Wire (Oct 1, 2012)
-
Business Wire (Sep 10, 2012)
-
Business Wire (Aug 29, 2012)
-
at MarketWatch.com (Aug 8, 2012)
-
Business Wire (Aug 7, 2012)
CRL vs. ETF Alternatives
Company Description
Charles River has been operating since 1947 and during that time, we have undergone several changes to our business structure. Charles River Laboratories International, Inc. was incorporated in 1994. In 2000, we completed the initial public offering of Charles River Laboratories International,... More
